002252 Share Price | Shanghai RAAS Blood Products Co., Ltd. Stock Analysis & Recommendation

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

N/A

Shareholding

FII

N/A

DII

N/A

Promoter

N/A

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Poor long term growth as Net Sales has grown by an annual rate of 18.93% and Operating profit at 5.81% over the last 5 years

With a fall in PBT of -20.11%, the company declared Very Negative results in Mar 26

Below par performance in long term as well as near term

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

CNY 33,354 Million (Large Cap)

P/E

21.00

Industry P/E

Dividend Yield

0.98%

Debt Equity

0.06

Return on Equity

4.14%

Price to Book

1.03

Revenue and Profits:

Net Sales:

1,700 Million

(Quarterly Results - Jun 2026)

Net Profit:

345 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

7.53%

6 Months

-16.94%

1 Year

-26.14%

2 Years

-24.01%

3 Years

-27.43%

4 Years

-7.58%

5 Years

-28.47%

Shanghai RAAS Blood Products Co., Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

18.93%

EBIT Growth (5y)

5.81%

EBIT to Interest (avg)

100.00

Debt to EBITDA (avg)

0.27

Net Debt to Equity (avg)

-0.12

Sales to Capital Employed (avg)

0.24

Tax Ratio

22.21%

Dividend Payout Ratio

20.14%

Pledged Shares

Institutional Holding

ROCE (avg)

7.12%

ROE (avg)

6.49%

Valuation key factors

Factor

Value

P/E Ratio

Industry P/E

Price to Book Value

0.87

EV to EBIT

22.61

EV to EBITDA

19.83

EV to Capital Employed

0.88

EV to Sales

4.45

PEG Ratio

Dividend Yield

1.93%

ROCE (Latest)

3.90%

ROE (Latest)

4.14%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

Bearish

RSI

No Signal

Bollinger Bands

Bullish

Mildly Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Mildly Bullish

Bearish

Dow Theory

Mildly Bearish

No Trend

OBV

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot

No data for shareholding present.

Shareholding Compare (%holding)

No data for shareholding present.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 12.62% vs 20.08% in Mar 2026",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2026 is 9.37% vs 197.08% in Mar 2026",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Jun'26",
        "Mar'26",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "1,700.00",
          "val2": "1,509.50",
          "chgp": "12.62%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "325.90",
          "val2": "391.40",
          "chgp": "-16.73%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "20.00",
          "val2": "20.80",
          "chgp": "-3.85%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "345.40",
          "val2": "315.80",
          "chgp": "9.37%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "151.90%",
          "val2": "214.40%",
          "chgp": "-6.25%",
          "chgp_class": "negative"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -10.03% vs 2.56% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -28.13% vs 23.43% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "7,329.90",
          "val2": "8,147.50",
          "chgp": "-10.03%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,824.30",
          "val2": "2,308.30",
          "chgp": "-20.97%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "44.60",
          "val2": "1.00",
          "chgp": "4,360.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-97.10",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "1,576.60",
          "val2": "2,193.80",
          "chgp": "-28.13%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "216.00%",
          "val2": "256.70%",
          "chgp": "-4.07%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]